54.34
Nektar Therapeutics Aktie (NKTR) Neueste Nachrichten
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September - MSN
Wealth Enhancement Advisory Services LLC Reduces Stake in Nektar Therapeutics $NKTR - MarketBeat
Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today - MSN
Nektar Therapeutics' (NKTR) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
What MACD and RSI say about Nektar TherapeuticsJuly 2025 Fed Impact & Smart Money Movement Tracker - newser.com
Evaluating Nektar Therapeutics with trendline analysisJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Moderate to Severe Atopic Dermatitis Pipeline Drugs Insights Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight - The Globe and Mail
How Nektar Therapeutics (ITH0) stock responds to job market shiftsNew Guidance & Reliable Price Breakout Alerts - newser.com
Sector ETF performance correlation with Nektar Therapeutics2025 Technical Patterns & AI Driven Price Predictions - newser.com
Quantitative breakdown of Nektar Therapeutics recent moveJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Gainplan LLC Buys New Shares in Nektar Therapeutics $NKTR - MarketBeat
Public Employees Retirement System of Ohio Sells 121,001 Shares of Nektar Therapeutics $NKTR - MarketBeat
Nektar Therapeutics (NKTR): Examining Valuation After Breakthrough Eczema Drug Trial Results Spark Investor Interest - Sahm
How Nektar Therapeutics (ITH0) stock reacts to weak economyDividend Hike & Real-Time Stock Movement Alerts - newser.com
What analysts say about Nektar Therapeutics stockSwing Trading Watchlist & Build Wealth With Expert Timing Advice - earlytimes.in
Real time social sentiment graph for Nektar TherapeuticsTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com
Is a relief rally coming for Nektar Therapeutics holdersTrade Entry Summary & Advanced Swing Trade Entry Plans - newser.com
How analysts rate Nektar Therapeutics stock today2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Why Nektar Therapeutics (NKTR) Is Up 8.8% After Positive Phase 2b Rezpegaldesleukin Data at EADV - simplywall.st
Nektar Therapeutics (NASDAQ:NKTR) Reaches New 52-Week HighTime to Buy? - MarketBeat
Nektar Therapeutics stock hits 52-week high at 61.24 USD By Investing.com - Investing.com South Africa
Nektar Therapeutics stock hits 52-week high at 61.24 USD - Investing.com
The biotech scorecard for the fourth quarter: 36 stock-moving events to watch - statnews.com
BTIG Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $100 - 富途牛牛
Building trade automation scripts for Nektar TherapeuticsJuly 2025 PostEarnings & Community Trade Idea Sharing Platform - newser.com
Voya Investment Management LLC Raises Stock Holdings in Nektar Therapeutics $NKTR - MarketBeat
Diffuse Large B Cell Lymphoma Pipeline Drugs Report 2025: Tracking Novel Therapies, Competitive Scenarios, and R&D Innovations Across Key Indications - Barchart.com
Metastatic Renal Cell Carcinoma Pipeline 2025: Pioneering Clinical Developments by 40+ Global Leaders – DelveInsight | Novartis Pharmaceuticals, Vaccibody, SillaJen, Chongqing Precision Biotech - Barchart.com
Nektar Therapeutics Hits New 52-Week High of $61.06, Up 229.74% - Markets Mojo
Goldman Sachs Group Inc. Decreases Position in Nektar Therapeutics $NKTR - MarketBeat
Parallel Advisors LLC Sells 14,767 Shares of Nektar Therapeutics $NKTR - MarketBeat
Should you hold or exit Nektar Therapeutics nowJuly 2025 Sentiment & Stepwise Trade Execution Plans - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):